×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Amylyx Pharmaceuticals Inc. (AMLX) NASDAQ

$1.73 (0.05) (-2.81%)

Market Cap: $117.65M

As of 05/24/24 04:00 PM EDT. Market closed.

(AMLX)

Amylyx Pharmaceuticals Inc. (AMLX)
NASDAQ

$1.73
(0.05) (-2.81%)

Market Cap: $117.65M

As of 05/24/24 04:00 PM EDT. Market closed.

Add to Portfolio

Amylyx Pharmaceuticals, Inc is a biopharmaceutical company headquartered in Cambridge, Massachusetts. Amylyx is best known for AMX0035, an experimental therapy for amyotrophic lateral ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full Time Employees
259
Address
.
PRICE CHART FOR AMYLYX PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.79
Previous Close
$1.78
Days Range
$1.73 - $1.81
52 week range
$1.70 - $26.44
Volume
1,077,168
Avg. Volume (30 days)
1,457,386
Market Cap
$117.65M
Dividend Yield
-
P/E
(1.65)
Shares Outstanding
68,005,749
Open
$1.79
Previous Close
$1.78
Days Range
$1.73 - $1.81
52 week range
$1.70 - $26.44
Volume
1,077,168
Avg. Volume (30 days)
1,457,386
Market Cap
$117.65M
Dividend Yield
-
P/E
(1.65)
Shares Outstanding
68,005,749
FINANCIAL STATEMENTS FOR AMYLYX PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR AMYLYX PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Quimi DaphneDirectorMay 15, 2024 Buy$1.892,2504,2525,000May 16, 2024, 07:37 PM
Quimi DaphneDirectorMay 14, 2024 Buy$1.882,7505,1842,750May 16, 2024, 07:37 PM
Mazzariello GinaChief Legal OfficerMay 15, 2024 Sale$1.8810,45519,654151,477May 16, 2024, 07:36 PM
Cohen Joshua BCo-Chief Executive OfficerMar 05, 2024 Sale$18.734,13577,4403,023,002Mar 07, 2024, 04:05 PM
Klee Justin B.Co-Chief Executive OfficerMar 05, 2024 Sale$18.734,13577,4402,959,308Mar 07, 2024, 04:05 PM
FRATES JAMES MChief Financial OfficerMar 05, 2024 Sale$18.731,79233,560134,784Mar 07, 2024, 04:05 PM
Mazzariello GinaChief Legal OfficerMar 05, 2024 Sale$18.731,54028,84181,372Mar 07, 2024, 04:05 PM
Mazzariello GinaChief Legal OfficerFeb 23, 2024 Sale$18.762,83853,23146,245Feb 27, 2024, 05:59 PM
Klee Justin B.Co-Chief Executive OfficerJan 09, 2024 Sale$16.335,84195,3722,836,776Jan 11, 2024, 05:11 PM
FRATES JAMES MChief Financial OfficerJan 09, 2024 Sale$16.332,71644,347112,035Jan 11, 2024, 05:11 PM
Cohen Joshua BCo-Chief Executive OfficerJan 09, 2024 Sale$16.335,84195,3722,900,470Jan 11, 2024, 05:10 PM
Yeramian Patrick DChief Medical OfficerJan 09, 2024 Sale$16.332,81245,915205,605Jan 11, 2024, 05:04 PM
Olinger MargaretChief Commercial OfficerDec 27, 2023 Option Exercise$0.3725,0009,250276,108Dec 29, 2023, 04:07 PM
Firestone KarenDirectorDec 15, 2023 Buy$14.974,00059,8805,000Dec 19, 2023, 04:37 PM
Cohen Joshua BCo-Chief Executive OfficerNov 16, 2023 Option Exercise$1.5763,694100,0002,906,311Nov 20, 2023, 08:20 PM
FRATES JAMES MChief Financial OfficerAug 23, 2023 Option Exercise$6.8818,165124,975106,341Aug 24, 2023, 04:15 PM
Mazzariello GinaChief Legal OfficerAug 15, 2023 Sale$20.886,164128,68649,083Aug 17, 2023, 04:35 PM
Olinger MargaretChief Commercial OfficerJul 12, 2023 Option Exercise$0.3720,0007,400251,108Jul 14, 2023, 04:20 PM
FRATES JAMES MChief Financial OfficerMay 16, 2023 Option Exercise$6.8832,500223,60088,176May 18, 2023, 08:54 PM
FRATES JAMES MChief Financial OfficerMay 16, 2023 Sale$26.9432,500875,45156,176May 18, 2023, 08:54 PM
Yeramian Patrick DChief Medical OfficerMay 15, 2023 Option Exercise$5.6811,96567,991220,382May 17, 2023, 04:58 PM
Yeramian Patrick DChief Medical OfficerMay 15, 2023 Sale$29.0311,965347,358208,417May 17, 2023, 04:58 PM
Yeramian Patrick DChief Medical OfficerApr 17, 2023 Option Exercise$0.9949,57949,058257,996Apr 19, 2023, 07:45 PM
Yeramian Patrick DChief Medical OfficerApr 17, 2023 Sale$30.5449,5791,513,942208,717Apr 19, 2023, 07:45 PM
Morningside Venture Investments Ltd10% OwnerMar 29, 2023 Sale$30.4529,048884,5126,997,302Mar 31, 2023, 04:05 PM
Morningside Venture Investments Ltd10% OwnerMar 28, 2023 Sale$30.37100,0003,037,0007,026,350Mar 29, 2023, 04:05 PM
Morningside Venture Investments Ltd10% OwnerMar 27, 2023 Sale$30.5060,9641,859,5617,154,350Mar 29, 2023, 04:05 PM
FRATES JAMES MChief Financial OfficerMar 16, 2023 Option Exercise$6.8832,500223,60066,509Mar 24, 2023, 06:48 PM
FRATES JAMES MChief Financial OfficerMar 16, 2023 Sale$31.8932,5001,036,45935,713Mar 24, 2023, 06:48 PM
Yeramian Patrick DChief Medical OfficerMar 16, 2023 Option Exercise$2.5749,578127,262253,877Mar 24, 2023, 06:45 PM
Yeramian Patrick DChief Medical OfficerMar 16, 2023 Sale$31.8754,6271,741,200201,666Mar 24, 2023, 06:45 PM
Morningside Venture Investments Ltd10% OwnerMar 21, 2023 Sale$31.9163,4482,024,4947,216,121Mar 23, 2023, 04:05 PM
Klee Justin B.Co-Chief Executive OfficerMar 16, 2023 Sale$31.86100,0003,186,2362,796,062Mar 20, 2023, 08:31 PM
MILNE GEORGE M JRDirectorMar 16, 2023 Sale$31.8935,0001,116,072863,937Mar 20, 2023, 08:25 PM
Yeramian Patrick DChief Medical OfficerMar 16, 2023 Sale$31.8754,6271,741,200152,088Mar 20, 2023, 08:25 PM
Firestone KarenDirectorMar 16, 2023 Buy$31.991,00031,9901,000Mar 20, 2023, 08:22 PM
Cohen Joshua BCo-Chief Executive OfficerMar 16, 2023 Sale$31.86100,0003,186,3362,796,541Mar 20, 2023, 08:21 PM
FRATES JAMES MChief Financial OfficerMar 16, 2023 Sale$31.8932,5001,036,4593,213Mar 20, 2023, 08:18 PM
Morningside Venture Investments Ltd10% OwnerMar 16, 2023 Sale$32.559,122296,9217,250,762Mar 17, 2023, 04:05 PM
Morningside Venture Investments Ltd10% OwnerMar 15, 2023 Sale$33.27150,0004,990,9977,300,950Mar 16, 2023, 04:11 PM
Morningside Venture Investments Ltd10% OwnerMar 14, 2023 Sale$34.5470,7142,442,4627,409,884Mar 16, 2023, 04:11 PM
Morningside Venture Investments Ltd10% OwnerMar 02, 2023 Sale$33.7550,0001,687,5007,480,598Mar 06, 2023, 09:10 AM
Mazzariello GinaChief Legal OfficerFeb 24, 2023 Sale$34.493,586123,67237,414Feb 28, 2023, 04:42 PM
Morningside Venture Investments Ltd10% OwnerFeb 22, 2023 Sale$34.7350,0001,736,3527,532,710Feb 28, 2023, 04:06 PM
Morningside Venture Investments Ltd10% OwnerFeb 23, 2023 Sale$35.5750,0001,778,2677,581,709Feb 24, 2023, 04:13 PM
Morningside Venture Investments Ltd10% OwnerFeb 22, 2023 Sale$36.0050,0001,799,8367,640,682Feb 24, 2023, 04:13 PM
Yeramian Patrick DChief Medical OfficerJan 06, 2023 Sale$36.302,03473,831204,928Jan 10, 2023, 07:22 PM
Cohen Joshua BCo-Chief Executive OfficerJan 06, 2023 Sale$36.305,968216,6292,894,463Jan 10, 2023, 07:20 PM
FRATES JAMES MChief Financial OfficerJan 06, 2023 Sale$36.302,65896,48134,831Jan 10, 2023, 07:20 PM
Olinger MargaretChief Commercial OfficerJan 06, 2023 Sale$36.302,40387,225215,098Jan 10, 2023, 07:19 PM
Klee Justin B.Co-Chief Executive OfficerJan 06, 2023 Sale$36.305,968216,6292,894,463Jan 10, 2023, 07:12 PM
FRATES JAMES MChief Financial OfficerDec 30, 2022 Option Exercise$6.885,00034,40036,667Jan 04, 2023, 09:33 PM
VIKING GLOBAL INVESTORS LP10% OwnerSep 09, 2022 Sale$30.23700,00021,159,7534,082,713Sep 09, 2022, 09:48 PM
VIKING GLOBAL INVESTORS LP10% OwnerSep 08, 2022 Sale$29.37700,00020,559,8864,789,821Sep 09, 2022, 09:48 PM
ALS Invest 1 B.V.10% OwnerJul 06, 2022 Sale$20.7060,6091,254,6425,937,577Jul 08, 2022, 06:44 PM
Klee Justin B.Co-Chief Executive OfficerMay 05, 2022 Option Exercise$0.37334,520123,7722,898,585May 06, 2022, 04:05 PM
Cohen Joshua BCo-Chief Executive OfficerMay 05, 2022 Option Exercise$0.37334,520123,7722,898,585May 06, 2022, 04:05 PM
Morningside Venture Investments Ltd10% OwnerJan 11, 2022 Buy$19.00263,1585,000,00210,678,808Mar 17, 2022, 05:14 PM
Morningside Venture Investments Ltd10% OwnerJan 11, 2022 Buy$19.00263,1585,000,00210,678,808Jan 25, 2022, 04:46 PM
VIKING GLOBAL INVESTORS LP10% OwnerJan 11, 2022 Buy$19.002,300,00043,700,0002,300,000Jan 13, 2022, 09:05 PM
FONTEYNE PAUL R.DirectorJan 06, 2022 Buy$19.003,94774,9933,947Jan 10, 2022, 08:37 PM
Cheng IsaacDirectorJan 06, 2022 Buy$19.006,578124,9826,578Jan 10, 2022, 08:35 PM
MILNE GEORGE M JRDirectorJan 06, 2022 Buy$19.0026,315499,985221,396Jan 10, 2022, 08:34 PM
Olinger MargaretChief Commercial OfficerJan 06, 2022 Buy$19.006,842129,998216,758Jan 10, 2022, 08:30 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Quimi DaphneDirector05/15/20244,252
Quimi DaphneDirector05/14/20245,184
Mazzariello GinaChief Legal Officer05/15/202419,654
Cohen Joshua BCo-Chief Executive Officer03/05/202477,440
Klee Justin B.Co-Chief Executive Officer03/05/202477,440
FRATES JAMES MChief Financial Officer03/05/202433,560
Mazzariello GinaChief Legal Officer03/05/202428,841
Mazzariello GinaChief Legal Officer02/23/202453,231
Klee Justin B.Co-Chief Executive Officer01/09/202495,372
FRATES JAMES MChief Financial Officer01/09/202444,347
Cohen Joshua BCo-Chief Executive Officer01/09/202495,372
Yeramian Patrick DChief Medical Officer01/09/202445,915
Olinger MargaretChief Commercial Officer12/27/20239,250
Firestone KarenDirector12/15/202359,880
Cohen Joshua BCo-Chief Executive Officer11/16/2023100,000
FRATES JAMES MChief Financial Officer08/23/2023124,975
Mazzariello GinaChief Legal Officer08/15/2023128,686
Olinger MargaretChief Commercial Officer07/12/20237,400
FRATES JAMES MChief Financial Officer05/16/2023223,600
FRATES JAMES MChief Financial Officer05/16/2023875,451
Yeramian Patrick DChief Medical Officer05/15/202367,991
Yeramian Patrick DChief Medical Officer05/15/2023347,358
Yeramian Patrick DChief Medical Officer04/17/202349,058
Yeramian Patrick DChief Medical Officer04/17/20231,513,942
Morningside Venture Investments Ltd10% Owner03/29/2023884,512
Morningside Venture Investments Ltd10% Owner03/28/20233,037,000
Morningside Venture Investments Ltd10% Owner03/27/20231,859,561
FRATES JAMES MChief Financial Officer03/16/2023223,600
FRATES JAMES MChief Financial Officer03/16/20231,036,459
Yeramian Patrick DChief Medical Officer03/16/2023127,262
Yeramian Patrick DChief Medical Officer03/16/20231,741,200
Morningside Venture Investments Ltd10% Owner03/21/20232,024,494
Klee Justin B.Co-Chief Executive Officer03/16/20233,186,236
MILNE GEORGE M JRDirector03/16/20231,116,072
Yeramian Patrick DChief Medical Officer03/16/20231,741,200
Firestone KarenDirector03/16/202331,990
Cohen Joshua BCo-Chief Executive Officer03/16/20233,186,336
FRATES JAMES MChief Financial Officer03/16/20231,036,459
Morningside Venture Investments Ltd10% Owner03/16/2023296,921
Morningside Venture Investments Ltd10% Owner03/15/20234,990,997
Morningside Venture Investments Ltd10% Owner03/14/20232,442,462
Morningside Venture Investments Ltd10% Owner03/02/20231,687,500
Mazzariello GinaChief Legal Officer02/24/2023123,672
Morningside Venture Investments Ltd10% Owner02/22/20231,736,352
Morningside Venture Investments Ltd10% Owner02/23/20231,778,267
Morningside Venture Investments Ltd10% Owner02/22/20231,799,836
Yeramian Patrick DChief Medical Officer01/06/202373,831
Cohen Joshua BCo-Chief Executive Officer01/06/2023216,629
FRATES JAMES MChief Financial Officer01/06/202396,481
Olinger MargaretChief Commercial Officer01/06/202387,225
Klee Justin B.Co-Chief Executive Officer01/06/2023216,629
FRATES JAMES MChief Financial Officer12/30/202234,400
VIKING GLOBAL INVESTORS LP10% Owner09/09/202221,159,753
VIKING GLOBAL INVESTORS LP10% Owner09/08/202220,559,886
ALS Invest 1 B.V.10% Owner07/06/20221,254,642
Klee Justin B.Co-Chief Executive Officer05/05/2022123,772
Cohen Joshua BCo-Chief Executive Officer05/05/2022123,772
Morningside Venture Investments Ltd10% Owner01/11/20225,000,002
Morningside Venture Investments Ltd10% Owner01/11/20225,000,002
VIKING GLOBAL INVESTORS LP10% Owner01/11/202243,700,000
FONTEYNE PAUL R.Director01/06/202274,993
Cheng IsaacDirector01/06/2022124,982
MILNE GEORGE M JRDirector01/06/2022499,985
Olinger MargaretChief Commercial Officer01/06/2022129,998
Load More Insider Transactions
FUNDS WITH A POSITION IN AMYLYX PHARMACEUTICALS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.4,474,7220.0003%11.8%Other
VIKING GLOBAL INVESTORS LP2,962,5550.16%ExitedGrowth At A Reasonable Price
FARALLON CAPITAL MANAGEMENT LLC1,150,2210.01%NewEvent Driven, Value
GEODE CAPITAL MANAGEMENT, LLC1,066,2450.00028%3.45%Other
D. E. SHAW & CO., INC.1,042,5830.00253%90.61%Other
RENAISSANCE TECHNOLOGIES LLC704,6000.00315%888.39%Other
ALPS ADVISORS INC139,2500.0028%180.02%Other
AQR CAPITAL MANAGEMENT LLC116,4890.00056%399.01%Other
TUDOR INVESTMENT CORP ET AL12,7530.00023%-62.1%Event Driven, Other
BALYASNY ASSET MANAGEMENT L.P.19,6980.00054%ExitedEvent Driven
CHANGE IN SHARES OUTSTANDING FOR AMYLYX PHARMACEUTICALS INC
STOCK BUYBACKS FOR AMYLYX PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
-2.42%
1Q
03/31/2024
09/30/2023
-2.72%
2Q
03/31/2024
06/30/2023
-3.25%
3Q
03/31/2024
03/31/2023
-4.25%
4Q
03/31/2024
12/31/2022
3.61%
5Q
03/31/2024
09/30/2022
15.92%
6Q
03/31/2024
06/30/2022
16.44%
7Q
03/31/2024
03/31/2022
31.49%
8Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
-2.42%
1Q
09/30/2023
-2.72%
2Q
06/30/2023
-3.25%
3Q
03/31/2023
-4.25%
4Q
12/31/2022
3.61%
5Q
09/30/2022
15.92%
6Q
06/30/2022
16.44%
7Q
03/31/2022
31.49%
8Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AMYLYX PHARMACEUTICALS INC
LOADING...